These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6318778)

  • 1. Cytokine modulation of chondrocyte proteinase release.
    Herman JH; Greenblatt D; Khosla RC; Appel AM
    Arthritis Rheum; 1984 Jan; 27(1):79-91. PubMed ID: 6318778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine modulation of chondrocyte metabolism--in vivo and in vitro effects of piroxicam.
    Herman JH; Appel AM; Khosla RC; Kelch KS; Hess EV
    Inflammation; 1984 Jun; 8 Suppl():S125-37. PubMed ID: 6384036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The simultaneous release by bone explants in culture and the parallel activation of procollagenase and of a latent neutral proteinase that degrades cartilage proteoglycans and denatured collagen.
    Vaes G; Eeckhout Y; Lenaers-Claeys G; François-Gillet C; Druetz JE
    Biochem J; 1978 May; 172(2):261-74. PubMed ID: 208518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines.
    Bryson H; Bunning RA; Feltell R; Kam CM; Kerrigan J; Powers JC; Buttle DJ
    Arch Biochem Biophys; 1998 Jul; 355(1):15-25. PubMed ID: 9647662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic modulation of cartilage metabolism.
    Herman JH; Appel AM
    J Rheumatol; 1987 May; 14 Spec No():83-5. PubMed ID: 3305941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral proteinases from articular chondrocytes in culture. I. A latent collagenase that degrades human cartilage type II collagen.
    Malemud CJ; Norby DP; Sapolsky AI; Matsuta K; Howell DS; Moskowitz RW
    Biochim Biophys Acta; 1981 Feb; 657(2):517-29. PubMed ID: 6260204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of proteases from cartilage cells as a result of activation by a macrophage factor--effects of some anti-inflammatory drugs.
    Phadke K; Nanda S; Lee K
    Biochem Pharmacol; 1979 Dec; 28(24):3671-3. PubMed ID: 231451
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.
    Gowen M; Wood DD; Ihrie EJ; Meats JE; Russell RG
    Biochim Biophys Acta; 1984 Feb; 797(2):186-93. PubMed ID: 6320902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cartilage remodeling by IL-1: evidence for autocrine synthesis of IL-1 by chondrocytes.
    Towle CA; Trice ME; Ollivierre F; Awbrey BJ; Treadwell BV
    J Rheumatol; 1987 May; 14 Spec No():11-3. PubMed ID: 3040990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high molecular weight collagenase inhibitor made by rabbit chondrocytes in cell culture.
    Morris GM
    Matrix; 1989 Mar; 9(2):127-34. PubMed ID: 2542742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes.
    Kandel RA; Petelycky M; Dinarello CA; Minden M; Pritzker KP; Cruz TF
    J Rheumatol; 1990 Jul; 17(7):953-7. PubMed ID: 2170644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation.
    Jasin HE; Dingle JT
    J Clin Invest; 1981 Sep; 68(3):571-81. PubMed ID: 7276159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: a comparative study with rat chondrocytes and cartilage entities.
    Cipolletta C; Jouzeau JY; Gegout-Pottie P; Presle N; Bordji K; Netter P; Terlain B
    Br J Pharmacol; 1998 Aug; 124(8):1719-27. PubMed ID: 9756389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification, characterization and inhibition of human skin collagenase.
    Woolley DE; Glanville RW; Roberts DR; Evanson JM
    Biochem J; 1978 Feb; 169(2):265-76. PubMed ID: 204294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.
    Grässel S; Opolka A; Anders S; Straub RH; Grifka J; Luger TA; Böhm M
    Arthritis Rheum; 2009 Oct; 60(10):3017-27. PubMed ID: 19790046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between anticollagen antibodies and chondrocytes.
    Takagi T; Jasin HE
    Arthritis Rheum; 1992 Feb; 35(2):224-30. PubMed ID: 1310410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradative enzyme systems in cartilage.
    Ehrlich MG; Armstrong AL; Treadwell BV; Mankin HJ
    Clin Orthop Relat Res; 1986 Dec; (213):62-8. PubMed ID: 3022974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs.
    Bendele AM; Hulman JF; Harvey AK; Hrubey PS; Chandrasekhar S
    Toxicol Pathol; 1990; 18(2):304-12. PubMed ID: 2169070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation.
    Jasin HE
    J Clin Invest; 1983 Dec; 72(6):2014-9. PubMed ID: 6358260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.